Coronary Artery Disease Market by Type, End-User - Global Forecast 2025-2030- Product Image

Sale

Coronary Artery Disease Market by Type, End-User - Global Forecast 2025-2030

Report
199 Pages
October 2024
Region: Global
360iResearch™
ID: 5977693

UP TO €681EUR$697USD£568GBP OFF until Dec 31^st 2024

The Coronary Artery Disease Market grew from USD 11.88 billion in 2023 to USD 12.53 billion in 2024. It is expected to continue growing at a CAGR of 5.68%, reaching USD 17.49 billion by 2030.

Coronary Artery Disease (CAD) is a prevalent cardiovascular condition characterized by the narrowing of coronary arteries due to plaque buildup, leading to reduced blood flow to the heart. The increase in sedentary lifestyles, rising prevalence of obesity, and aging populations globally are necessitating advancements in the CAD market. This market includes diagnostics, therapeutics, and monitoring solutions key to managing heart health. Application spans from early detection technologies, such as imaging and biomarkers, to therapeutic interventions like stents and pharmaceuticals, with end-use in hospitals, diagnostic centers, and specialized heart treatment units.

Market growth is driven by technological advancements, a surge in minimally invasive procedures, and increased healthcare expenditure worldwide. The integration of Artificial Intelligence (AI) in diagnostic imaging and the development of bioresorbable stents exemplify crucial growth areas. Expanding healthcare infrastructure in emerging economies further offers potential opportunities. To capitalize, businesses should focus on innovation in telemedicine for remote monitoring and AI-enabled predictive analytics for personalized treatment plans. Firms can also explore partnerships with tech companies to develop smart wearable devices that assist in early detection and continuous monitoring, aligning with the global trend towards preventive healthcare.

However, the market faces challenges such as stringent regulatory environments, high costs associated with advanced therapies, and a lack of awareness about early CAD symptoms in developing regions, which can hamper growth. Issues related to reimbursement policies for new technologies also pose barriers. Overcoming these hurdles requires raising awareness about CAD risks and advocating for policy changes to support broader access and affordability. Promoting lifestyle changes through public health initiatives could also mitigate widespread incidence. Innovations focusing on cost-effective and accessible diagnostic tools, as well as exploring genetic and stem cell research for long-term treatment solutions, represent promising avenues for future business ventures, ensuring a responsive and adaptive market nature that meets evolving patient needs.

Understanding Market Dynamics in the Coronary Artery Disease Market

The Coronary Artery Disease Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising incidences of coronary artery disease due to aging populations
- Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
Market Restraints
- High cost of advanced therapeutic devices and limited commercialization of advanced technologies
Market Opportunities
- Advancements and improvements in CAD management products
- Continuous expansion of minimally invasive procedures and surgery centers
Market Challenges
- Problems associated with product recalls due to safety concerns

Exploring Porter’s Five Forces for the Coronary Artery Disease Market

Porter’s Five Forces framework further strengthens the insights of the Coronary Artery Disease Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Coronary Artery Disease Market

External macro-environmental factors deeply influence the performance of the Coronary Artery Disease Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Coronary Artery Disease Market

The Coronary Artery Disease Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Coronary Artery Disease Market

The Coronary Artery Disease Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Coronary Artery Disease Market

The Coronary Artery Disease Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coronary Artery Disease Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences, FUJIFILM Holdings Corporation, GE HealthCare Technologies, Inc., Genesee Biomedical Inc., Getinge AB, Hitachi, Ltd., Koninklijke Philips N.V., Medtronic PLC, Merck KGaA, MicroPort Scientific Corporation, Siemens Healthineer AG, Stryker Corporation, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Diagnostics
  - Cardiac Catheterization & Angiogram
  - Echocardiogram
  - Electrocardiogram
  - Exercise Stress Test
  - Heart CT Scan
  - Nuclear Stress Test
- Treatment
  - Medications
    - Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin
    - Aspirin
    - Beta-blockers
    - Calcium Channel Blockers
    - Cholesterol Drugs
    - Ranolazine
  - Surgeries
    - Coronary Angioplasty & Stent Placement
    - Coronary Artery Bypass Graft Surgery
End-User
- Ambulatory Surgery Centers
- Diagnostic Centers
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of coronary artery disease due to aging populations
5.1.1.2. Expansion of healthcare infrastructure with increasing investments in healthcare infrastructure
5.1.2. Restraints
5.1.2.1. High cost of advanced therapeutic devices and limited commercialization of advanced technologies
5.1.3. Opportunities
5.1.3.1. Advancements and improvements in CAD management products
5.1.3.2. Continuous expansion of minimally invasive procedures and surgery centers
5.1.4. Challenges
5.1.4.1. Problems associated with product recalls due to safety concerns
5.2. Market Segmentation Analysis
5.2.1. Type: Growing need for surgeries to manage CAD effectively and improve the quality of life
5.2.2. End-User: Higher preferences for hospitals and clinics that offer integrated CAD care
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Coronary Artery Disease Market, by Type

6.1. Introduction
6.2. Diagnostics
6.2.1. Cardiac Catheterization & Angiogram
6.2.2. Echocardiogram
6.2.3. Electrocardiogram
6.2.4. Exercise Stress Test
6.2.5. Heart CT Scan
6.2.6. Nuclear Stress Test
6.3. Treatment
6.3.1. Medications
6.3.1.1. Angiotensin-converting Enzyme Inhibitors & Angiotensin II Receptor Blockers Nitroglycerin
6.3.1.2. Aspirin
6.3.1.3. Beta-blockers
6.3.1.4. Calcium Channel Blockers
6.3.1.5. Cholesterol Drugs
6.3.1.6. Ranolazine
6.3.2. Surgeries
6.3.2.1. Coronary Angioplasty & Stent Placement
6.3.2.2. Coronary Artery Bypass Graft Surgery

7. Coronary Artery Disease Market, by End-User

7.1. Introduction
7.2. Ambulatory Surgery Centers
7.3. Diagnostic Centers
7.4. Hospitals & Clinics

8. Americas Coronary Artery Disease Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Coronary Artery Disease Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Coronary Artery Disease Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. Abbott Introduces Enhanced Xience Sierra Stent System for Improved Cardiac Care
11.3.2. Innovative Startup Revolutionizes Coronary Artery Disease Detection with AI Technology
11.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. CORONARY ARTERY DISEASE MARKET RESEARCH PROCESS
FIGURE 2. CORONARY ARTERY DISEASE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. CORONARY ARTERY DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CORONARY ARTERY DISEASE MARKET DYNAMICS
TABLE 7. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CARDIAC CATHETERIZATION & ANGIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ECHOCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY EXERCISE STRESS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HEART CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY NUCLEAR STRESS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN II RECEPTOR BLOCKERS NITROGLYCERIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CHOLESTEROL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY RANOLAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ANGIOPLASTY & STENT PLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFT SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 55. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 57. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 58. CANADA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CORONARY ARTERY DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 87. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 89. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 90. CHINA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 93. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 95. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 96. INDIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 105. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 107. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 108. JAPAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 143. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 144. THAILAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 162. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 163. DENMARK CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 168. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 169. EGYPT CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 174. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 175. FINLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 178. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 179. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 181. FRANCE CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 186. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 187. GERMANY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 196. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 197. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 198. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 199. ITALY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 215. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 216. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 217. NORWAY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 220. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 221. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 222. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 223. POLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 226. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 227. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 228. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 229. QATAR CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 248. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 250. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 251. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 252. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 253. SPAIN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 269. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 270. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 271. TURKEY CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY SURGERIES, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM CORONARY ARTERY DISEASE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. CORONARY ARTERY DISEASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 285. CORONARY ARTERY DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Coronary Artery Disease Market, which are profiled in this report, include:

Abbott Laboratories
B. Braun SE
Becton, Dickinson and Company
Biotronik SE & Co. KG
Boston Scientific Corporation
Canon Medical Systems Corporation
Edwards Lifesciences
FUJIFILM Holdings Corporation
GE HealthCare Technologies, Inc.
Genesee Biomedical Inc.
Getinge AB
Hitachi, Ltd.
Koninklijke Philips N.V.
Medtronic PLC
Merck KGaA
MicroPort Scientific Corporation
Siemens Healthineer AG
Stryker Corporation
Teleflex Incorporated
Terumo Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 12.53 Billion
Forecasted Market Value ( USD ) by 2030	$ 17.49 Billion
Compound Annual Growth Rate	5.6%
Regions Covered	Global
No. of Companies Mentioned	20

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3464EUR$3,545USD£2,892GBP €3849EUR$3,939USD£3,213GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6128EUR$6,272USD£5,116GBP €6809EUR$6,969USD£5,684GBP

Understanding Market Dynamics in the Coronary Artery Disease Market

Exploring Porter’s Five Forces for the Coronary Artery Disease Market

Applying PESTLE Analysis to the Coronary Artery Disease Market

Analyzing Market Share in the Coronary Artery Disease Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Coronary Artery Disease Market

Strategic Recommendations for Success in the Coronary Artery Disease Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Coronary Artery Disease Global Market Report 2024

Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By Application, By End User, By Region: Market Insights and Forecast (2020-2030)

Translational Research in Coronary Artery Disease. Pathophysiology to Treatment

JACC's Imaging Cases in Cardiovascular Intervention

CT and MR in Cardiology

About the Coronary Artery Disease Market